Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy

Technology appraisal guidance
Reference number: TA117
Published: 24 January 2007

TA117 Hyperparathyroidism - cinacalcet: Appendix B - proposal paper presented to the Institute's Guidance Executive

TA117 Hyperparathyroidism - cinacalcet: Appendix B - proposal paper presented to the Institute's Guidance Executive

TA117 Hyperparathyroidism - cinacalcet: Appendix B - proposal paper presented to the Institute's Guidance Executive
29 April 2013
(342.21 Kb 39 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 26 April 2013